Genetron CEO on Covid-19 Diagnostic Kits, Pandemic, Oncology

The transcript discusses a company's journey in developing a COVID-19 testing kit amidst the pandemic, highlighting the motivation, strategy, and impact on the broader industry. It also covers the company's successful IPO and the shift to online marketing. The challenges faced in expanding their oncology business in China, including regulatory hurdles and the need for education, are also addressed.

In what ways has the COVID-19 pandemic changed the broader healthcare industry?

What role did online platforms play in the company's recent IPO?

How does the company plan to address the regulatory challenges in developing new technologies?